Sunday, March 15, 2009

U. Minnesota agrees to asbestos penalties

The University of Minnesota has agreed to pay $60,000 in penalties for two asbestos violations, Minnesota Pollution Control Agency officials said Thursday, even though school officials deny responsibility for the violations.

The University’s General Counsel Mark Rotenberg said University officials disagree there were any violations, but agreed to pay the fine because they “didn’t think it was worth arguing about any further.”

As part of the agreement reached between the University and the MPCA, the University will pay two $5,000 fines , one for each violation uncovered in 2007 at the Centennial Showboat in St. Paul and UMore Park in Rosemount.

The University has also agreed to give $50,000 to an environmental project that will support on-campus research related to asbestos issues.

Money to pay the fines will come out of the University’s general fund, Rotenberg said.

The violation at the Centennial Showboat, which is dry-docked in St. Paul and serves as a theater venue for University students, involved 45 cubic yards of asbestos left over from the dismantling of a boiler.

Over the course of last summer, more than 13,000 people attended performances at the Showboat, spokeswoman Jennie Germain said.

When the boiler was taken apart, the asbestos wasn’t properly disposed and dried out, increasing the chance of asbestos fibers becoming airborne, Derek Pemble, pollution control specialist in the asbestos and demolition program at the MPCA, said.

Rotenberg said the boiler was dismantled as part of an effort by the landowner to salvage the boat.

The landowner hired a specialist to make sure the ship complied with asbestos regulations, and the specialist found the ship to be in compliance, Rotenberg said.

“The subcontractor who provided the certificate that he was an asbestos abatement expert simply didn’t do a good job,” Rotenberg said. “It was our boat, so we agreed to pay the $5,000 fine.”

UMore Park’s violation stemmed from asbestos panels left from buildings demolished in the 1940s.

During recent removal of trees and brush from the 8,000-acre research site, some panels were crushed, resulting in a possible airborne release of asbestos fibers, Pemble said.

The University contests that asbestos from the site became airborne, Rotenberg said, something Pemble admitted “is hard to prove.”

Rotenberg said both sites have been cleaned up and noted that the University having to pay fines for environmental violations is “quite rare.”

Monday, March 9, 2009

NeoPlas Treatment prevent the growth of cancer tumors

Recent study and research suggest that a newly, innovative cancer treatment called "NeoPlas" treatment has recently stopped the growth of aggressive sarcomas in two patients. One of the patients was diagnosed with malignant fibrous histiocytoma (MFH) and the other patient was diagnosed with desmoplastic small round cell tumor (DSRCT). After multiple surgeries and several different chemotherapy regimens had failed, the cancers were continuing to spread to other areas of their bodies. However, after just eight weeks of the NeoPlas treatment, scans revealed that both patients’ cancers had stopped spreading and some tumors had actually regressed. NeoPlas treatment is a combination of lovastatin and interferon. The treatment is also being offered for patients with colon cancer, renal cancer, melanoma, pancreatic cancer and mesothelioma. Although NeoPlas treatment is different from chemotherapy and is free of its side effects, fatigue often results in most patients.

Saturday, January 31, 2009

World's First Asbestos Research Center - Sydney

Australian Prime Minister Kevin Rudd presided over the opening dedication of the Bernie Banton Asbestos Diseases Research Institute (BBADRI) on January 20, 2009. Located on the grounds of Sydney's Concord Hospital, the $12 million facility is the world's largest stand alone institute dedicated entirely to the advancement of scientific investigations into asbestos-caused malignant pleural mesothelioma (MPM), an aggressive, deadly, and incurable form of lung cancer. Public and private donation funded, the BBADRI will be partially staffed by physicians and researchers from Concord Hospital.

For more details, please refer http://www.mesotheliomaweb.org/jan200930b.htm

Sunday, January 25, 2009

Haining Yang awarded for Asbestos and Mesothelioma Research

Haining Yang, M.D., a young female scientist specializes in the cancer research has been awarded for the asbestos and mesothelioma research. She was selected among fifty nine total applicants for asbestos related research grant and has been awarded grants total of $220,000 for her research on the asbestos and mesothelioma cancer. The grant will be distributed over a two year period. The first grant totals $100,000 was awarded by the Mesothelioma Applied Research Foundation for performing research on developing therapeutic and preventative interventions. The second grant totals $120,000 was awarded by Hawaii's community Foundations Leahi Fund for her research and funding for study involving the detection of mesothelioma.

Tuesday, January 13, 2009

Mesothelioma treatment using Egg cells of Northern Leopard Frog

Mesothelioma is a highly aggressive cancer due to asbestos exposure. Once asbestos particles inhaled, they embedded in the lining of lungs and cause malignant diseases like mesothelioma, asbestosis and lung cancer. There are several treatment methodologies for mesothelioma viz. surgery, chemotherapy and radiological techniques are available. Recently, Researchers, Hospitals, Pharmaceutical companies and Universities are involved with the new scientific investigations into asbestos and related cancer in an effort to develop novel and potentially curative cancer treatments.

An innovative treatment method is discovered by the Scientists from the United States and United Kingdom called amphinase which cause the tumors to die. Amphinase has shown the best results in treating brain tumors. A synthetic version of a molecule found in the egg cells of the Northern leopard frog may provide the world with the first drug treatment for various malignant tumors. The Northern leopard frog is a species of leopard frog that is native to certain regions of the United States and Canada. Amphinase is the second anti-tumor drug to be isolated by Alfacell Corporation from the Northern leopard frog. The other drug, ONCONASE (R) (ranpirnase) is currently in a late-stage clinical trial as a potential treatment for malignant mesothelioma.

The drug's key researcher, Professor Ravi Acharya, Department of Biology and Biochemistry claims that amphinase is highly specific in recognizing and destroying cancer and tumor cells.

Thursday, January 1, 2009

MicroRNA-based Molecular Diagnostic Test for Mesothelioma and Lung Cancer

The recently discovered and naturally occurring microRNAs (miRNAs) act as master regulators and have the potential to form the basis for a new class of diagnostics and therapeutics. Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate protein activity through microRNAs could provide the means to treat a wide range of human diseases.

Rosetta Genomics, a Philadelphia-based developer of microRNA-based molecular diagnostic tests, has developed a comprehensive mesothelioma diagnosis exam that is now commercially available. The test is the third microRNA-based diagnostic test created by the lab and is known as miRview™ meso. miRview™ meso differentiates mesothelioma, a cancer connected to asbestos exposure, from other carcinomas in the lung. Currently, there is no single diagnostic test that is entirely conclusive for this differentiation.

Scare Report: Vitamin Supplements offer Negative Effect against Cancer

In my earlier post (http://mesotheliomacancernewsinformation.blogspot.com/2008/11/vitamin-c-opt-for-cancer-treatment.html), I have mentioned that supplement of Vitamin C is a new and different solution for the cancer treatment. But the recent research and studies performed in the United States show that there is no effect on the risk of cancer though injecting Vitamin supplements. The new studies proved that taking the Vitamins have no beneficial result in the rate of cancer development.

Most of the patients and victims affected by the cancer get disappointed after hearing such a panic information.

LinkWithin